Navigation Links
U.S. Orthopedic Stem Cell Market to Grow 68% in 2009
Date:4/7/2009

Orthopedic Stem Cell Market to Reach $228 Million by 2014

VANCOUVER, April 7 /PRNewswire/ - According to a report by iData Research (www.idataresearch.net), an international medical device and dental market research firm, the U.S. market for stem cells used in orthopedic therapy will grow to an estimated $228 million by 2014. Applications are currently focused on spinal fusion surgery, mostly for arthritis, but will eventually expand to include the fixation of traumatic fractures and the regeneration of worn joint cartilage.

Since 2005, adult stem cell products have been commercially available for use in spinal fusion surgery, the common treatment for arthritis and other bone defects. More than 29,000 patients have benefited from orthopedic stem cell therapy, which eliminates the pain and surgical complexity of traditional procedures. The Obama administration's lifting of research restrictions has renewed public interest in applications for embryonic stem cell therapies.

"The aging population will be the main driver for stem cell therapies, as it is for the overall orthopedic marketplace," says Kamran Zamanian PhD., CEO of iData, "The prevalence of osteoarthritis and degenerative joint disease will increase in the near future, driving the market for stem cell therapies. Stem cells are an advancement over traditional treatments because, unlike other treatments, they can potentially regenerate healthy tissue."

According to the report, over 60% of adults over 64 suffer from osteoarthritis. This implies an enormous future market for all orthopedic stem cell applications. This market will grow as baby boomers age and embryonic stem cell use increases. The report estimates a compound annual growth rate of 33% through 2014.

"Stem cell therapy in orthopedics is not only ahead of other medical applications, such as cardiology and neurology," says Zamanian. "It is also less socially contentious because it is based on adult stem cell lines, side-stepping the political difficulties with embryonic research, and increasing potential patient acceptance."

About iData Research

iData Research (www.idataresearch.net) is an international market research and consulting group focused on providing market intelligence for the medical device, dental and pharmaceutical industries in categories such as: Orthopedics, Sports Medicine, Spine, Cardiovascular, CRM, Dental, Endoscopy, Imaging, Ophthalmics, Patient Monitoring, Urology, Women's Health and more.

To learn more about iData's services, view this 3-minute Movie at: www.idataresearch.net/discoveridata.html


'/>"/>
SOURCE iData Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Black Hills Orthopedics & Spine Center Selects Sage Intergy EHR to Improve Clinical, Operational and Financial Efficiencies
2. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
3. Northeast Ohio's Center for Orthopedics Saves Patients Time with Online Next-Day Appointment Scheduling for its Open Cast Room
4. Wuesthoff Health System and Broadlane Continue Exclusive Relationship; Orthopedic Consulting Initiative Yields Significant Savings
5. Team of orthopedic surgeons and kinesiologists win hippest of awards
6. Ascension Orthopedics Introduces the Silicone PIP Implant System
7. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
8. Quick Orthopedic Repair Can Save Young Shoulders
9. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
10. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
11. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... inaugural SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student ... MS in Educational Leadership and Administration at St. Thomas University in Miami, Florida, ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... “Letters From Home”: a moving compilation of letters that ... God. “Letters From Home” is the creation of published author, John Allred, a passionate ... Jerry Savelle Ministries International, who has traveled and ministered on four continents. , “It ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
Breaking Medicine Technology: